Holen Sie sich die Stockscreener-App
224.99
0.26%
-0.59
Handel nachbörslich:
224.99
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$225.58
Offen:
$225.34
24-Stunden-Volumen:
1.05M
Relative Volume:
0.54
Marktkapitalisierung:
$52.94B
Einnahmen:
$244.67B
Nettoeinkommen (Verlust:
$1.68B
KGV:
32.38
EPS:
6.9487
Netto-Cashflow:
$5.51B
1W Leistung:
+0.33%
1M Leistung:
+5.90%
6M Leistung:
+50.26%
1J Leistung:
+78.21%
1-Tages-Spanne:
$222.59
$225.90
1-Wochen-Bereich:
$213.75
$229.15
52-Wochen-Spanne:
$120.72
$230.81
Cardinal Health Inc Stock (CAH) Company Profile
Firmenname
Cardinal Health Inc
Sektor
Branche
Telefon
(614) 757-3033
Adresse
7000 CARDINAL PLACE, DUBLIN, OH
Compare CAH vs MCK, COR, HSIC, ACH
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
224.99 | 53.08B | 244.67B | 1.68B | 5.51B | 6.9487 |
|
MCK
Mckesson Corporation
|
946.97 | 115.93B | 397.96B | 4.55B | 9.64B | 34.77 |
|
COR
Cencora Inc
|
360.23 | 70.03B | 325.78B | 1.64B | 3.61B | 8.3139 |
|
HSIC
Henry Schein Inc
|
78.03 | 9.09B | 12.50B | 314.00M | 421.00M | 2.44 |
|
ACH
Accendra Health Inc
|
2.41 | 180.99M | 0 | 0 | 0 | 0.00 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-06-03 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-02-05 | Hochstufung | Jefferies | Hold → Buy |
| 2025-01-08 | Hochstufung | TD Cowen | Hold → Buy |
| 2025-01-07 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-01-06 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-12-13 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-12-04 | Fortgesetzt | Mizuho | Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-09 | Hochstufung | Argus | Hold → Buy |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-14 | Eingeleitet | Wells Fargo | Underweight |
| 2023-07-10 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-03-31 | Eingeleitet | Citigroup | Neutral |
| 2023-02-03 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2022-11-04 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-05-26 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-05-18 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-04-12 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-08-06 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-08-05 | Herabstufung | BofA Securities | Buy → Underperform |
| 2021-05-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2021-01-08 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-11-02 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-09-25 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-07-20 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-05-15 | Hochstufung | UBS | Neutral → Buy |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-03-20 | Hochstufung | BofA/Merrill | Underperform → Buy |
| 2020-02-12 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-02-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-12-16 | Herabstufung | Guggenheim | Buy → Neutral |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-08-27 | Herabstufung | Argus | Buy → Hold |
| 2019-08-20 | Hochstufung | Guggenheim | Neutral → Buy |
| 2019-04-18 | Eingeleitet | Guggenheim | Neutral |
| 2019-01-17 | Eingeleitet | UBS | Neutral |
| 2018-11-16 | Herabstufung | Leerink Partners | Outperform → Mkt Perform |
| 2018-04-24 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-04-02 | Hochstufung | Argus | Hold → Buy |
| 2018-03-08 | Eingeleitet | Barclays | Equal Weight |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Underperform |
| 2018-01-05 | Eingeleitet | Evercore ISI | In-line |
Alle ansehen
Cardinal Health Inc Aktie (CAH) Neueste Nachrichten
Cardinal Health Stock Is Trading Near Record Levels: Here’s the Path to $467 - TIKR.com
Cardinal Health Inc (NYSE:CAH) Shows Strong Growth and Technical Momentum - ChartMill
Vanguard Group Inc. Has $4.84 Billion Stock Position in Cardinal Health, Inc. $CAH - MarketBeat
Zacks.com featured highlights include Boot Barn, Brinker International, Tapestry and Cardinal Health - Yahoo Finance
Columbus Zoo board welcomes 2 new members from AEP, Cardinal Health - AOL.com
Wall Street Analysts See Cardinal (CAH) as a Buy: Should You Invest? - Finviz
Moving Averages: What’s the MACD signal for Cardinal Health Inc.July 2025 Market Mood & Accurate Buy Signal Alerts - mfd.ru
Cardinal Health (CAH) Stock Analysis: A Healthcare Giant With 12.23% Upside Potential - DirectorsTalk Interviews
Shell Asset Management Co. Sells 14,094 Shares of Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health's (NYSE:CAH) Dividend Will Be $0.5107 - Yahoo Finance
Assetmark Inc. Has $10.72 Million Holdings in Cardinal Health, Inc. $CAH - MarketBeat
(02/16/26) Top Picks 2026: Cardinal Health Inc. (CAH) - moneyshow.com
Top Picks 2026- Cardinal Health Inc. CAH - Yahoo Finance
Cardinal Health, Inc. $CAH Shares Purchased by Varma Mutual Pension Insurance Co - MarketBeat
Cardinal Health (NYSE:CAH) Upgraded by Zacks Research to Strong-Buy Rating - MarketBeat
Florida Financial Advisors LLC Acquires Shares of 9,989 Cardinal Health, Inc. $CAH - MarketBeat
Assessing Cardinal Health (CAH) Valuation After Strong Q2 Beat And Raised 2026 Profit Guidance - Sahm
Cardinal Health’s Broad Profit Growth Raises Questions On Valuation Gap - Yahoo Finance
Cardinal Health Inc (NYSE:CAH) Boosts Logistics Reliability On Nyse Composite Today - Kalkine Media
Cardinal Health (CAH) Valuation Check After Recent Pullback And Strong Long Term Returns - Yahoo Finance
Best Momentum Stock to Buy for February 13th - The Globe and Mail
Cardinal Health, Inc. (NYSE:CAH) to Issue $0.51 Quarterly Dividend - MarketBeat
Are Investors Undervaluing Cardinal Health (CAH) Right Now? - Yahoo Finance
Cardinal Health's (NYSE:CAH) Solid Earnings Are Supported By Other Strong Factors - Yahoo Finance
LSV Asset Management Reduces Stake in Cardinal Health, Inc. $CAH - MarketBeat
Cookson Peirce & Co. Inc. Sells 7,855 Shares of Cardinal Health, Inc. $CAH - MarketBeat
Caprock Group LLC Makes New $2.25 Million Investment in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health Board of Directors Approves Quarterly Dividend - GuruFocus
Cardinal Health Keeps Quarterly Dividend at $0.5107 per Share, Payable April 15 to Holders of Record April 1 - marketscreener.com
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term - Yahoo Finance
The 5 Most Interesting Analyst Questions From Cardinal Health’s Q4 Earnings Call - The Globe and Mail
The 5 Most Interesting Analyst Questions From Cardinal Health's Q4 Earnings Call - Finviz
Cardinal Health Inc (NYSE:CAH): A GARP Stock with Affordable Growth and Reasonable Valuation - ChartMill
Why The Narrative Around Cardinal Health (CAH) Is Shifting With Fresh Targets And Fair Value Assumptions - Yahoo Finance
Cardinal Health (NYSE:CAH) Given New $248.00 Price Target at Argus - MarketBeat
ING Groep NV Sells 77,635 Shares of Cardinal Health, Inc. $CAH - MarketBeat
Wells Fargo Raises Price Target for Cardinal Health (CAH) | CAH Stock News - GuruFocus
Cardinal Health (NYSE:CAH) Given New $243.00 Price Target at JPMorgan Chase & Co. - MarketBeat
Nasogastric Tubes Market Is Booming Worldwide 2026-2033 | - openPR.com
Wells Fargo Adjusts Price Target on Cardinal Health to $256 From $237, Maintains Overweight Rating - marketscreener.com
Candriam S.C.A. Acquires 19,155 Shares of Cardinal Health, Inc. $CAH - MarketBeat
Versor Investments LP Takes $2.09 Million Position in Cardinal Health, Inc. $CAH - MarketBeat
Fresh Look At Cardinal Health (CAH) Valuation After Mixed Recent Share Performance - Sahm
Earnings Winners: 2 Buy Rated Stocks Raising Guidance - Finviz
Lasix ONYU Gains Major Distributor Access Through Cardinal Health and Cencora - Pharmaceutical Commerce
Morgan Stanley raises Cardinal Health, Inc. (CAH) price target after strong Q2 - MSN
Morgan Stanley Raises Cardinal Health, Inc. (CAH) Price Target After Strong Q2 - Finviz
Cardinal Health CEO Jason Hollar says Central Ohio is key to achieving record revenue - The Business Journals
ProShare Advisors LLC Has $173.98 Million Stock Position in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health, Inc. (CAH) shares gain favor as Citi turns bullish on specialist assets - MSN
Cardinal Health, Inc. (NYSE:CAH) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock? - 富途牛牛
Finanzdaten der Cardinal Health Inc-Aktie (CAH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.07%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):